%0 Journal Article
%A Herrmann, Ken
%A Walz, Jochen
%A MacLennan, Steven
%A Briganti, Alberto
%A Cornford, Philip
%A Czernin, Johannes
%A Eiber, Matthias
%A Fanti, Stefano
%A Fendler, Wolfgang P
%A Fizazi, Karim
%A Gafita, Andrei
%A Gillessen, Silke
%A Goffin, Karolien
%A Hadaschik, Boris
%A Hofman, Michael S
%A Hope, Thomas A
%A Maurer, Tobias
%A Morgans, Alicia K
%A Morris, Michael J
%A Murphy, Declan G
%A Oprea-Lager, Daniela E
%A Ost, Piet
%A ÓSullivan, Joe M
%A Rouvière, Olivier
%A Sandhu, Shahneen
%A Sartor, Oliver
%A Sathekge, Mike Machaba
%A Tempany, Clare
%A Witjes, Wim
%A Emmett, Louise
%A Bjartell, Anders S
%T SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis.
%J European urology
%V nn
%@ 0302-2838
%C Amsterdam [u.a.]
%I Elsevier Science
%M DKFZ-2025-01908
%P nn
%D 2025
%Z epub
%X Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is an evolving diagnostic tool for prostate cancer. There is a need to harmonise existing guidelines and reporting recommendations for PSMA PET/CT. The Standardised PSMA PET/CT Analysis and Reporting Consensus (SPARC) project aims to consolidate classifications and recommendations by a multidisciplinary and international group of experts under one cohesive framework, establishing a dynamic and evolving structure for PSMA PET/CT reporting.We employed a cross-sectional iterative process to define opinions and evaluate consensus. Thirty expert panel members, representing diverse specialities and geographic areas, were selected. A methods expert led the design, data collection, and analysis. Five groups of international multidisciplinary prostate cancer experts convened for literature review and formulation of statements on standardised reporting, detection, primary staging, biochemical recurrence, and treatment response. The groups compiled 91 statements for a two-round modified Delphi survey. The 'RAND appropriateness method' was used for the analysis.Consensus increased to 93
%K Positron emission tomography/computed tomography (Other)
%K Prostate cancer (Other)
%K Prostate-specific membrane antigen (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:40945999
%R 10.1016/j.eururo.2025.08.005
%U https://inrepo02.dkfz.de/record/304585